Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Molecular Partners AG

MOLN ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: BUY

Last Close

$4.01

▼ -1.72%

Market Cap $161.78M · Vol 770

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$161.78M

Micro Cap

Div Yield

N/A

EPS Growth

+23.12%

YoY

RSI (14)

42.58

Momentum

Beta

1.09

vs Market

52W High

$5.30

24.34% below

52W Low

$3.50

14.57% above

Volume

770

Avg 557

P/B

1.61

Price-to-book

ROE

N/A

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Molecular Partners AG (MOLN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MOLN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.07%

-0.74%

+2.56%

-4.98%

YTD

-6.74%

+6.37%

-7.82%

-80.09%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-77,812,697.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-47.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	1.61
P/FCF	N/A
EPS Growth	+23.12%
Outstanding Shares	40.37M

Technical Indicators

50-Day SMA	$4.14
200-Day SMA	$4.25
RSI (14)	42.58
Beta	1.09
52-Week High	$5.30
52-Week Low	$3.50

Volume Today	770
Avg Daily Volume (30D)	557
Relative Volume	1.38x
Volatility (10D)	61.09
Volatility (30D)	54.20
Free Float	100.00%

Analyst Consensus

BUY

Current Price $4.01

Mean Target $12.50

52W Low$3.50 52W High$5.30

Current

Target

$3.50 $5.30

Current Analyst target

+211.72% upside potential · 4 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG010B7DJV0

ISINUS60853G1067

CountrySwitzerland

Sub-IndustryBio Therapeutic Drugs

Earnings DateOct 30, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co., Ltd. +4.82% ARGX.BR argenx SE +1.64% ARGX argenx SE +0.62% INSM Insmed Incorporated -3.18% 2269.HK WuXi Biologics (Cayman) Inc. +4.55%

Company Profile

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.